Cargando…
Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy
This study retrospectively investigated the effect of neuromuscular electrical stimulation (NMES) for fatigue management in patients with advanced laryngeal cancer (ALC) receiving chemoradiotherapy. A total of 60 eligible patients with ALC receiving chemoradiotherapy were included. These patients we...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076145/ https://www.ncbi.nlm.nih.gov/pubmed/29995774 http://dx.doi.org/10.1097/MD.0000000000011370 |
_version_ | 1783344653330808832 |
---|---|
author | Zhang, Mei-jia Mu, Ji-wei Qu, Xiu-sheng Feng, Chong Zhao, Wei |
author_facet | Zhang, Mei-jia Mu, Ji-wei Qu, Xiu-sheng Feng, Chong Zhao, Wei |
author_sort | Zhang, Mei-jia |
collection | PubMed |
description | This study retrospectively investigated the effect of neuromuscular electrical stimulation (NMES) for fatigue management in patients with advanced laryngeal cancer (ALC) receiving chemoradiotherapy. A total of 60 eligible patients with ALC receiving chemoradiotherapy were included. These patients were assigned equally to a treatment group and a control group. Patients in the treatment group received NMES therapy and were treated for a total of 8 weeks, while the patients in the control group did not receive NMES therapy. The primary outcome was fatigue, measured by the multidimensional fatigue inventory (MFI). The secondary outcomes included anxiety and depression, measured by the Hospital Anxiety and Depression Scale (HADS), and sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI). All outcomes were evaluated before and after 8-week NMES treatment After 8-week NMES treatment, the patients in the treatment group did not exert better effect than patients in the control group in fatigue relief, measured by the MFI score, anxiety and depression decrease, assessed by HADS, and sleep quality improvement, evaluated by PSQI. The results of this study demonstrate that NMES may not benefit for fatigue relief in patients with ALC receiving chemoradiotherapy. Future studies should still focus on this topic and warrant these results. |
format | Online Article Text |
id | pubmed-6076145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-60761452018-08-17 Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy Zhang, Mei-jia Mu, Ji-wei Qu, Xiu-sheng Feng, Chong Zhao, Wei Medicine (Baltimore) Research Article This study retrospectively investigated the effect of neuromuscular electrical stimulation (NMES) for fatigue management in patients with advanced laryngeal cancer (ALC) receiving chemoradiotherapy. A total of 60 eligible patients with ALC receiving chemoradiotherapy were included. These patients were assigned equally to a treatment group and a control group. Patients in the treatment group received NMES therapy and were treated for a total of 8 weeks, while the patients in the control group did not receive NMES therapy. The primary outcome was fatigue, measured by the multidimensional fatigue inventory (MFI). The secondary outcomes included anxiety and depression, measured by the Hospital Anxiety and Depression Scale (HADS), and sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI). All outcomes were evaluated before and after 8-week NMES treatment After 8-week NMES treatment, the patients in the treatment group did not exert better effect than patients in the control group in fatigue relief, measured by the MFI score, anxiety and depression decrease, assessed by HADS, and sleep quality improvement, evaluated by PSQI. The results of this study demonstrate that NMES may not benefit for fatigue relief in patients with ALC receiving chemoradiotherapy. Future studies should still focus on this topic and warrant these results. Wolters Kluwer Health 2018-07-13 /pmc/articles/PMC6076145/ /pubmed/29995774 http://dx.doi.org/10.1097/MD.0000000000011370 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Zhang, Mei-jia Mu, Ji-wei Qu, Xiu-sheng Feng, Chong Zhao, Wei Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy |
title | Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy |
title_full | Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy |
title_fullStr | Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy |
title_full_unstemmed | Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy |
title_short | Effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy |
title_sort | effect of neuromuscular electrical stimulation for fatigue management in patients with advanced laryngeal cancer receiving chemoradiotherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076145/ https://www.ncbi.nlm.nih.gov/pubmed/29995774 http://dx.doi.org/10.1097/MD.0000000000011370 |
work_keys_str_mv | AT zhangmeijia effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy AT mujiwei effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy AT quxiusheng effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy AT fengchong effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy AT zhaowei effectofneuromuscularelectricalstimulationforfatiguemanagementinpatientswithadvancedlaryngealcancerreceivingchemoradiotherapy |